drugset / Trial / NCT01451593

Neuroprotection With Phenytoin in Optic Neuritis

NCT01451593

RandomizedParallel-groupTriple-blindTreatment

Summary

Optic neuritis is caused by inflammation of the optic nerve and causes loss of vision in the affected eye. It is often associated with multiple sclerosis. Loss of vision after an attack of optic neuritis is caused by damage to the nerve fibres in the optic nerve. There are a number of factors that contribute to nerve fibre damage including increased levels of sodium within them, so blocking sodium entry could help to protect them against damage. The purpose of this study is determine whether phenytoin (which blocks sodium entry into cells) can protect against loss of nerve fibres and prevent loss of vision after optic neuritis.

Timeline

Start
2011-11
Primary completion
2014-12
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenytoin Unknown 4 mg/kg Oral
Subject Phenytoin Unknown 6 mg/kg Oral